BRAF and neoplasm: The rarity of similar cases, together with the lack of complete molecular characterization of the (primary or metastatic) tumor specimens (9) preclude potential identification of more specific clinical features of patients with BRAF V600E-mutated CRC who eventually develop metastatic infiltration of the skin and parotid gland.